{
  "report": {
    "report_id": "REP-20251216-633fc9",
    "title": "Remdesivir \u2013 COVID-19 \u2013 India (Repurposing Scan)",
    "generated_at": "2025-12-16T11:51:39.871179",
    "format": "pdf",
    "sections": {
      "executive_summary": [
        "Remdesivir is recognized and utilized in the treatment of COVID-19 with multiple publications from 2019 to 2024 indicating its clinical use, side effects, and treatment outcomes. Authoritative guidelines from WHO and NICE provide general disease management guidance. News sources note remdesivir's emergency approval, use guidelines, export bans, and legal issues in India during the COVID-19 pandemic."
      ],
      "clinical_trials": {
        "summary": {
          "active": 4,
          "completed": 1,
          "phase_distribution": {
            "Observational": 1,
            "Phase 1": 0,
            "Phase 2": 3,
            "Phase 3": 0,
            "Phase 4": 1
          }
        },
        "highlights": [
          "No Phase III trials identified in India"
        ],
        "top_trials": [
          {
            "trial_id": "NCT04854837",
            "title": "Safety of Remdesivir Treatment in COVID-19 Patients Requiring Hemodialysis",
            "phase": "Observational",
            "status": "Completed",
            "sponsor": "Semmelweis University",
            "locations": [
              "Hungary"
            ],
            "start_date": "2021-04-12"
          },
          {
            "trial_id": "NCT04386447",
            "title": "Phase II, Multicenter, Open-label, Rct With an Adaptive Design, to Assess Efficacy of Intravenous Administration of Oxytocin in Hospitalized Patients Affected by COVID-19",
            "phase": "Phase 2",
            "status": "Active",
            "sponsor": "Azienda Ospedaliero-Universitaria di Parma",
            "locations": [
              "Italy",
              "France"
            ],
            "start_date": "2020-09-01"
          },
          {
            "trial_id": "NCT04403477",
            "title": "Convalescent Plasma Transfusion Therapy in Severe COVID-19 Patients- a Tolerability, Efficacy and Dose-response Phase II RCT",
            "phase": "Phase 2",
            "status": "Active",
            "sponsor": "Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh",
            "locations": [
              "Bangladesh"
            ],
            "start_date": "2020-05-20"
          },
          {
            "trial_id": "NCT04321993",
            "title": "Treatment of Moderate to Severe Coronavirus Disease (COVID-19) in Hospitalized Patients",
            "phase": "Phase 2",
            "status": "Active",
            "sponsor": "Lisa Barrett",
            "locations": [
              "Canada"
            ],
            "start_date": "2020-04-17"
          },
          {
            "trial_id": "NCT06792214",
            "title": "Antiviral Strategies in the Prevention of Long-term Cardiovascular Outcomes Following COVID-19: The paxloviD/Remdesivir Effectiveness For the prEvention of loNg coviD (DEFEND) Clinical Trial",
            "phase": "Phase 4",
            "status": "Active",
            "sponsor": "Mount Sinai Hospital, Canada",
            "locations": [
              "Canada"
            ],
            "start_date": "2025-01-03"
          }
        ]
      },
      "guidelines_and_literature": {
        "guideline_points": [
          {
            "source": "WHO Guidelines",
            "publisher": "World Health Organization",
            "date": "2024-01-01",
            "recommendation": "Generic authoritative health guideline source (disease-specific guideline not mapped in MVP).",
            "url": "https://www.who.int/publications/guidelines"
          },
          {
            "source": "NICE Guidelines",
            "publisher": "National Institute for Health and Care Excellence (NICE)",
            "date": "2024-01-01",
            "recommendation": "Generic authoritative guideline repository (disease-specific guidance not mapped in MVP).",
            "url": "https://www.nice.org.uk/guidance"
          }
        ],
        "publication_points": [
          {
            "pmid": "39816292",
            "title": "Successful Sequential Treatment From Remdesivir to Molnupiravir for Prolonged COVID-19 in a Patient With Follicular Lymphoma and Renal Pelvic Carcinoma: A Case Report.",
            "journal": "Cureus",
            "year": 2024,
            "key_finding": "Title suggests a case report on sequential treatment involving remdesivir for prolonged COVID-19."
          },
          {
            "pmid": "39811032",
            "title": "Incidence of bradycardia with the use of remdesivir for coronavirus disease of 2019 and risk factor analysis.",
            "journal": "International journal of critical illness and injury science",
            "year": 2024,
            "key_finding": "Title suggests study on incidence and risk factors of bradycardia associated with remdesivir use in COVID-19."
          },
          {
            "pmid": "39739156",
            "title": "Treatment pattern and clinical outcomes of remdesivir in hospitalized COVID-19 patients with severe chronic kidney disease: a database analysis of acute care hospitals in Japan.",
            "journal": "Clinical and experimental nephrology",
            "year": 2025,
            "key_finding": "Title suggests analysis of remdesivir treatment patterns and outcomes in COVID-19 patients with severe kidney disease."
          }
        ],
        "news_signals": [
          {
            "headline": "Black marketing Remdesivir in Covid: Two get two years in jail - Times of India",
            "publisher": "Times of India",
            "date": "2025-05-28",
            "takeaway": "News on legal action against black marketing of Remdesivir during COVID-19 in India.",
            "url": "https://news.google.com/rss/articles/CBMi0AFBVV95cUxOaUNITURESlI0alNHb0lUOXg2ay1pMWgwN2pEcU5vMm1HRU90TWo0NmtiMlZ6NEUxQ0hKX2E2MGhNeWNlQWg2NjA3ZGRVakNfWTlDMlBiSkN6QldIclZXMmlVZjluMlV5N05ZYWtSZ2JiRXNIcVNDYVZ6MTc5M3U1YzFQYjVzd3pTTHkzdlk1bHM1ZXhDTGdFWUpvRnFUUEUtSHdKZnoxRXdyOEJ0bTd4NndKVGRFYXI2WDZYV3BaTHRveHFYTDlZVmpod3lZMnh00gHWAUFVX3lxTE9SVEZkVThmR3duZGxIejFIWGROQ2tibTh4UUlFZFhiNWFrSkNidkZDaWhUU0FpaEIxdC1fVHgweWZLaDV4SmtFRVcyQWhqMUMyaFpza25fQ09sLWRnWXlvRmxzc0h0QVkzbWJYSzRfelFXYlYzMFV0MXRmTmhiMVVQVFNEV29udlJwbFBIaC1VcnEtb0JwUC1LUmUzdWQ4NWVseWx4VXRuUmVVdEJNcjZLVHR1ZlB6M1k4cEVzZldsU1Z6N01XV0VsY2JiLXNMenRPRDJuNXc?oc=5"
          },
          {
            "headline": "Coronavirus: Pune Municipal Corporation Issues Guidelines for Use of Remdesivir in COVID-19 Patients - The Bridge Chronicle",
            "publisher": "The Bridge Chronicle",
            "date": "2025-05-29",
            "takeaway": "Local guidelines issued in Pune, India for remdesivir use in COVID-19 patients.",
            "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxORkZIRTJWZXN1RElqS25TSkRid29pb3M4dlRGdU1Lbzd5TU51QUQwVGhUUlZQMkhQMDdma3Jxa2FxRW9mcWJPVmtkVXlDRWg5RmR6S3VfY01TSzhqaUJLcldXbldzcndlX0g4SmNxQVBOZGlYSFduaTJQLU9UMlR0QnBveHppUUZPR01xcVZ0a0RzclJpTWhrUGV0Nzl0NFhFYlHSAa8BQVVfeXFMTUlxYnQ5XzhoRkV5Q0QwcUNhUzRhSDRpOVNzb050UnRYaE9fWFVjalFraEhXSVZNaVJDeTl4RVdUYmk3X1h6UmU5MzJ5LVdvWVFPWkFLTFh1RnVucUtMSHBsMmdCTVRvcUJVUjdxdVQ4R0hHU1k0bVVaN01pbkpxRkxCdXJXX1EwbkktWEtTLXpaSEZNY0czRkloNFBSbmFPNFF6RThYb3ZuUzhoWUJ4TQ?oc=5"
          },
          {
            "headline": "What does the widespread use of Remdesivir in COVID-19 management in India and short supply of it teach us? - orfonline.org",
            "publisher": "orfonline.org",
            "date": "2021-05-06",
            "takeaway": "Discussion on implications of widespread remdesivir use and supply issues during COVID-19 in India.",
            "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxQT0x1WU9UOFFhMkhmN3NsS3ZzeHpTR3FGVmVNa2E3RnBGTjhHcG5Dc3hlTFNkYU5CQVVnbTFJNld4SWlzTkVKYU1LTEFjaFZ5Q0pscnFYMURBSENUQ19QLWhhdkluRnNoMGwtX1Jad3BaOVJzcXZuRk15QWh0R0QxMm1hSmZhR1dtVUR0U1FnVFh6MDRxTzVQVg?oc=5"
          },
          {
            "headline": "COVID digest: India bans export of remdesivir treatment drug - DW",
            "publisher": "DW",
            "date": "2021-04-11",
            "takeaway": "India banned export of remdesivir during COVID-19 to maintain domestic supply.",
            "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxNeUc5MXhhUXh4OXhQbE5Ob1ROWEtscTdxU0xyYksxZml3c1hudWNwRmdieFVOU3oybnN5LWpiUUVpR05ad3QxNl9ua3JmdW5SOUN0Qkp6LTNrMkRKdFA0M1JTRVBQd0c5cGdNSktxX0VybnlaMWVFQkJiNG5Cb0dDQXFETDVGMFdkMEpQS0Y1cFctWWNXNUk5anR6bFVkMlI3UjVZOGxZaFd4dFXSAasBQVVfeXFMTlRZOUFsTWdyNVlueEdTdFZrc21KMENTbGNpQlBMZEgxc1Bydy15SnBUNldQVmxUZGFoaGVSQlo1VENOX2QwekVWeXNNSkoyc3BZSWpsM0ZTeE9uSG1Zb1A2UHJITEowSHNIQ0xIVDVSbXg1ZU1MSjhFVzZwRzE0VHI5SjNfWUU2YWUzejZTZVhIZi1raDNBTUNGdFdxX2hVVUdqdzVQME5MdDZj?oc=5"
          },
          {
            "headline": "India approves remdesivir for restricted emergency use in COVID-19 patients - European Pharmaceutical Review",
            "publisher": "European Pharmaceutical Review",
            "date": "2020-07-07",
            "takeaway": "India approved remdesivir for restricted emergency use during the COVID-19 pandemic.",
            "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxNVzk1UW5tNlRhb3FhNkUxZU41bEFxeWVidUlyVUNmUjBpV3hhYUliSERXS0VDTTU2cmZGNEhsVndkejZ4Q3F3ZjFSN2dmLU95TGxJWXhITkRmelBmNTRBWEZ2aElEcEdzRGpfd25lbEpIZGxtZ2NPVjFSOXFUMkJIN2oydm9nMTlYUlJQb2xsaXVaS0t4YzRoRjBKbHJQclVEMko4dk1pNFIwRnNIeHpvMnhTWFhubE9zV1Y0TDFWeGlrUWpoTElZeER4SWFQdw?oc=5"
          }
        ]
      },
      "repurposing_options": [
        {
          "option": "Targeted subgroup usage",
          "rationale": "Remdesivir is recognized and utilized in the treatment of COVID-19 with multiple publications from 2019 to 2024 indicating its clinical use, side effects, and treatment outcomes. Authoritative guidelines from WHO and NICE provide general disease management guidance. News sources note remdesivir's emergency approval, use guidelines, export bans, and legal issues in India during the COVID-19 pandemic.",
          "evidence": [
            "WHO Guidelines",
            "NICE Guidelines"
          ]
        }
      ],
      "risks_and_gaps": [
        "Limited late-stage clinical evidence",
        "Geography-specific data gaps for India"
      ],
      "references": [
        {
          "type": "guideline",
          "label": "WHO Guidelines",
          "url": "https://www.who.int/publications/guidelines"
        },
        {
          "type": "guideline",
          "label": "NICE Guidelines",
          "url": "https://www.nice.org.uk/guidance"
        },
        {
          "type": "publication",
          "label": "PMID:39816292",
          "url": "https://pubmed.ncbi.nlm.nih.gov/39816292/"
        },
        {
          "type": "publication",
          "label": "PMID:39811032",
          "url": "https://pubmed.ncbi.nlm.nih.gov/39811032/"
        },
        {
          "type": "publication",
          "label": "PMID:39739156",
          "url": "https://pubmed.ncbi.nlm.nih.gov/39739156/"
        },
        {
          "type": "trial",
          "label": "NCT04854837",
          "url": "https://clinicaltrials.gov/study/NCT04854837"
        },
        {
          "type": "trial",
          "label": "NCT04386447",
          "url": "https://clinicaltrials.gov/study/NCT04386447"
        },
        {
          "type": "trial",
          "label": "NCT04403477",
          "url": "https://clinicaltrials.gov/study/NCT04403477"
        },
        {
          "type": "trial",
          "label": "NCT04321993",
          "url": "https://clinicaltrials.gov/study/NCT04321993"
        },
        {
          "type": "trial",
          "label": "NCT06792214",
          "url": "https://clinicaltrials.gov/study/NCT06792214"
        }
      ]
    },
    "warnings": [
      "FTO requested but not executed in MVP",
      "Supply view requested but not executed in MVP"
    ],
    "file": {
      "type": "pdf",
      "path": "reports/remdesivir_covid-19_india.pdf"
    }
  }
}